Insider Shareholders with Direct Ownership of Cytek Biosciences, Inc. (CTKB)
This section provides a comprehensive overview of the insiders with direct ownership of Cytek Biosciences, Inc. (CTKB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cytek Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Ming Yan
CHIEF TECHNOLOGY OFFICER |
144,412 | 2,267,129 | 6,007,075 $30.7 Million | 53 |
Aug 19, 2024
Reduced 0.02%
|
|
Wenbin Jiang
PRESIDENT AND CEO |
240,090 | 2,997,569 | 5,156,896 $26.4 Million | 49 |
Sep 14, 2024
Reduced 3.73%
|
|
Patrik Jeanmonod
CHIEF FINANCIAL OFFICER |
72,324 | 65,927 | 97,465 $498,046 | 37 |
Mar 11, 2024
Reduced 1.92%
|
|
Allen Poirson
SVP BUS. AND CORP. DEV. |
26,978 | 9,931 | 56,825 $290,375 | 23 |
Aug 19, 2024
Reduced 1.27%
|
|
Valerie Barnett
CHIEF LEGAL OFFICER |
66,982 | 21,082 | 53,917 $275,515 | 24 |
Aug 19, 2024
Reduced 4.98%
|
| 42,999 | 16,000 | 26,999 $137,964 | 4 |
Nov 29, 2022
Added 33.06%
|
|
|
Paul Christopher Williams
CHIEF OPERATING OFFICER |
26,991 | 10,518 | 16,473 $84,177 | 14 |
Aug 19, 2024
Reduced 17.29%
|
|
Philippe Busque
SVP, GLOBAL SALES AND SERVICES |
17,342 | 6,757 | 10,585 $54,089 | 6 |
Aug 19, 2024
Reduced 7.52%
|
|
Jonathan Todd Garland
Chief Commercial Officer |
14,356 | 5,593 | 8,763 $44,778 | 4 |
Aug 18, 2023
Reduced 10.94%
|
|
Gisele Dion
Director |
5,000 | 0 | 5,000 $25,550 | 1 |
Jul 22, 2021
Added 50.0%
|
| 1,454 | 0 | 1,454 $7,429 | 1 |
Aug 19, 2024
Added 50.0%
|